Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Zhang, Qing Hong ^a   Chen, Qi ^a   Kang, Jia Rui ^a   Liu, Chen ^b   Dong, Ning ^a   Zhu, Xiao Mei ^a   Sheng, Zhi Yong ^a   Yao, Yong Ming ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Burns; Caspase 3; Gelsolin; Neuroinflammation; Septic encephalopathy

Indexed keywords

CASPASE 3; EOSIN; GELSOLIN; HEMATOXYLIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; NEURON SPECIFIC ENOLASE; PLACEBO; PROTEIN S 100; CYTOKINE; LEUKOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY SURFACE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE GENE; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; DRUG MEGADOSE; ENCEPHALITIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION REGULATION; GLIA CELL; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; THERMAL INJURY; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BURN; CATTLE; COGNITIVE DEFECT; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROGLIA; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; APOPTOSIS; BURNS; CASPASE 3; CATTLE; COGNITION DISORDERS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALITIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GELSOLIN; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICROGLIA; RANDOM ALLOCATION; SURVIVAL RATE; T-LYMPHOCYTES;

EID: 80053173045     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-118     Document Type: Article

References (62)

1. Zhou H, Andonegui G, Wong CH, Kubes P. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. J Immunol 2009, 183:5244-5250. 10.4049/jimmunol.0901309, 19786543.
2. Mora AG, Ritenour AE, Wade CE, Holcomb JB, Blackbourne LH, Gaylord KM. Posttraumatic stress disorder in combat casualties with burns sustaining primary blast and concussive injuries. J Trauma 2009, 66:S178-185. 10.1097/TA.0b013e31819ce2d6, 19359963.
3. Rosenberg M, Robertson C, Murphy KD, Rosenberg L, Mlcak R, Robert RS, Herndon DN, Meyer WJ. Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes. Burns 2005, 31:883-889. 10.1016/j.burns.2005.05.004, 16006044.
4. Wollgarten-Hadamek I, Hohmeister J, Demirakca S, Zohsel K, Flor H, Hermann C. Do burn injuries during infancy affect pain and sensory sensitivity in later childhood?. Pain 2009, 141:165-172. 10.1016/j.pain.2008.11.008, 19095356.
5. Li H, Ying D, Sun J, Bian X, Zhang Y, He B. Comparative observation with MRI and pathology of brain edema at the early stage of severe burn. Chin J Traumatol 2001, 4:226-230.
6. Li HT, Ying DJ, He XC, Sun JS, Chen L. Stereoscopic study on capillary density of early brain oedema in a dog postburn model. Injury 2009, 40:835-839. 10.1016/j.injury.2008.10.009, 19232588.
7. Zhang Q, Carter EA, Ma B, Fischman AJ, Tompkins RG. Burn-related metabolic and signaling changes in rat brain. J Burn Care Res 2008, 29:346-352. 10.1097/BCR.0b013e3181667387, 18354292.
8. Patel TH, Sprague S, Lai Q, Jimenez DF, Barone CM, Ding Y. Blood brain barrier (BBB) dysfunction associated with increased expression of tissue and urokinase plasminogen activators following peripheral thermal injury. Neurosci Lett 2008, 444:222-226. 10.1016/j.neulet.2008.08.020, 18718505.
9. Reyes R, Guo M, Swann K, Shetgeri SU, Sprague SM, Jimenez DF, Barone CM, Ding Y. Role of tumor necrosis factor-alpha and matrix metalloproteinase-9 in blood-brain barrier disruption after peripheral thermal injury in rats. J Neurosurg 2009, 110:1218-1226. 10.3171/2008.8.JNS08382, 19199470.
10. Flierl MA, Stahel PF, Touban BM, Beauchamp KM, Morgan SJ, Smith WR, Ipaktchi KR. Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?. Crit Care 2009, 13:215. 10.1186/cc7794, 2717412, 19638180.
11. Bloemsma GC, Dokter J, Boxma H, Oen IM. Mortality and causes of death in a burn centre. Burns 2008, 34:1103-1107. 10.1016/j.burns.2008.02.010, 18538932.
12. Chipp E, Milner CS, Blackburn AV. Sepsis in burns: a review of current practice and future therapies. Ann Plast Surg 2010, 65:228-236. 10.1097/SAP.0b013e3181c9c35c, 20606586.
13. Gatson JW, Maass DL, Simpkins JW, Idris AH, Minei JP, Wigginton JG. Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling. J Neuroinflammation 2009, 6:30. 10.1186/1742-2094-6-30, 2774304, 19849845.
14. Reyes R, Wu Y, Lai Q, Mrizek M, Berger J, Jimenez DF, Barone CM, Ding Y. Early inflammatory response in rat brain after peripheral thermal injury. Neurosci Lett 2006, 407:11-15. 10.1016/j.neulet.2006.07.071, 16935421.
15. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. Febs J 2009, 276:13-26. 10.1111/j.1742-4658.2008.06766.x, 19087196.
16. Barbizan R, Oliveira AL. Impact of acute inflammation on spinal motoneuron synaptic plasticity following ventral root avulsion. J Neuroinflammation 2010, 7:29. 10.1186/1742-2094-7-29, 2874529, 20441580.
17. Djukic M, Mildner A, Schmidt H, Czesnik D, Bruck W, Priller J, Nau R, Prinz M. Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. Brain 2006, 129:2394-2403. 10.1093/brain/awl206, 16891321.
18. D'Mello C, Le T, Swain MG. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 2009, 29:2089-2102. 10.1523/JNEUROSCI.3567-08.2009, 19228962.
19. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 2005, 14:595-604. 10.1089/scd.2005.14.595, 16305344.
20. Yin HL, Stossel TP. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 1979, 281:583-586. 10.1038/281583a0, 492320.
21. Janmey PA, Lind SE. Capacity of human serum to depolymerize actin filaments. Blood 1987, 70:524-530.
22. Goncalves AF, Dias NG, Moransard M, Correia R, Pereira JA, Witke W, Suter U, Relvas JB. Gelsolin is required for macrophage recruitment during remyelination of the peripheral nervous system. Glia 2010, 58:706-715.
23. Morley SC, Sung J, Sun GP, Martelli MP, Bunnell SC, Bierer BE. Gelsolin overexpression alters actin dynamics and tyrosine phosphorylation of lipid raft-associated proteins in Jurkat T cells. Mol Immunol 2007, 44:2469-2480. 10.1016/j.molimm.2006.09.024, 1945820, 17178161.
24. Jordan JR, Moore EE, Damle SS, Eckels P, Johnson JL, Roach JP, Redzic JS, Hansen KC, Banerjee A. Gelsolin is depleted in post-shock mesenteric lymph. J Surg Res 2007, 143:130-135. 10.1016/j.jss.2007.04.017, 2695490, 17950082.
25. Osborn TM, Verdrengh M, Stossel TP, Tarkowski A, Bokarewa M. Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther 2008, 10:R117. 10.1186/ar2520, 2592804, 18822171.
26. Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB. Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. PLoS One 2008, 3:e3712. 10.1371/journal.pone.0003712, 2577888, 19002257.
27. Wang H, Cheng B, Chen Q, Wu S, Lv C, Xie G, Jin Y, Fang X. Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients. Crit Care 2008, 12:R106. 10.1186/cc6988, 2575595, 18706105.
28. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007, 35:849-855. 10.1097/01.CCM.0000253815.26311.24, 17205019.
29. Christofidou-Solomidou M, Scherpereel A, Solomides CC, Christie JD, Stossel TP, Goelz S, DiNubile MJ. Recombinant plasma gelsolin diminishes the acute inflammatory response to hyperoxia in mice. J Investig Med 2002, 50:54-60. 10.2310/6650.2002.33518, 11813829.
30. Carlson DL, Maass DL, White J, Sikes P, Horton JW. Caspase inhibition reduces cardiac myocyte dyshomeostasis and improves cardiac contractile function after major burn injury. J Appl Physiol 2007, 103:323-330. 10.1152/japplphysiol.01255.2006, 17431085.
31. Rothenbach PASJ, Dahl B, O'Keefe E, Yamamoto Y, Lee WM, Horton JWYH, Turnage RH. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol 2004, 96:23-31.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
33. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251. 10.1126/science.285.5425.248, 10398600.
34. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
35. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. Embo J 2003, 22:5551-5560. 10.1093/emboj/cdg516, 213771, 14532127.
36. Yang QW, Lu FL, Zhou Y, Wang L, Zhong Q, Lin S, Xiang J, Li JC, Fang CQ, Wang JZ. HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab 2010, 31:593-605.
37. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195. 10.1038/nature00858, 12110890.
38. Streit WJ, Conde JR, Fendrick SE, Flanary BE, Mariani CL. Role of microglia in the central nervous system's immune response. Neurol Res 2005, 27:685-691.
39. Hara H, Kataoka S, Anan M, Ueda A, Mutoh T, Tabira T. The therapeutic effects of the herbal medicine, Juzen-taiho-to, on amyloid-beta burden in a mouse model of Alzheimer's disease. J Alzheimers Dis 2010, 20:427-439.
40. Shi FD, Piao WH, Kuo YP, Campagnolo DI, Vollmer TL, Lukas RJ. Nicotinic attenuation of central nervous system inflammation and autoimmunity. J Immunol 2009, 182:1730-1739.
41. Hirko AC, Meyer EM, King MA, Hughes JA. Peripheral transgene expression of plasma gelsolin reduces amyloid in transgenic mouse models of Alzheimer's disease. Mol Ther 2007, 15:1623-1629. 10.1038/sj.mt.6300253, 17609655.
42. Dickstein DL, Biron KE, Ujiie M, Pfeifer CG, Jeffries AR, Jefferies WA. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease. Faseb J 2006, 20:426-433. 10.1096/fj.05-3956com, 16507760.
43. Messaris E, Memos N, Chatzigianni E, Konstadoulakis MM, Menenakos E, Katsaragakis S, Voumvourakis C, Androulakis G. Time-dependent mitochondrial-mediated programmed neuronal cell death prolongs survival in sepsis. Crit Care Med 2004, 32:1764-1770. 10.1097/01.CCM.0000135744.30137.B4, 15286556.
44. Sharshar T, Gray F, Lorin de la Grandmaison G, Hopkinson NS, Ross E, Dorandeu A, Orlikowski D, Raphael JC, Gajdos P, Annane D. Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet 2003, 362:1799-1805. 10.1016/S0140-6736(03)14899-4, 14654318.
45. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998, 251:189-192. 10.1016/S0304-3940(98)00537-0, 9726375.
46. van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet 2010, 375:773-775. 10.1016/S0140-6736(09)61158-2, 20189029.
47. Depino AM, Earl C, Kaczmarczyk E, Ferrari C, Besedovsky H, del Rey A, Pitossi FJ, Oertel WH. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease. Eur J Neurosci 2003, 18:2731-2742. 10.1111/j.1460-9568.2003.03014.x, 14656322.
48. Zudaire E, Martinez A, Cuttitta F. Adrenomedullin and cancer. Regul Pept 2003, 112:175-183. 10.1016/S0167-0115(03)00037-5, 12667640.
49. Duan H, Chai J, Sheng Z, Yao Y, Yin H, Liang L, Shen C, Lin J. Effect of burn injury on apoptosis and expression of apoptosis-related genes/proteins in skeletal muscles of rats. Apoptosis 2009, 14:52-65. 10.1007/s10495-008-0277-7, 19009350.
50. Zhang JP, Ying X, Liang WY, Luo ZH, Yang ZC, Huang YS, Wang WC. Apoptosis in cardiac myocytes during the early stage after severe burn. J Trauma 2008, 65:401-408. discussion 408, 10.1097/TA.0b013e31817cf732, 18695479.
51. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661. 10.1126/science.1178331, 2887389, 20133564.
52. Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121:2437-2445.
53. Roy A, Hooper DC. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol 2007, 81:7993-7998. 10.1128/JVI.00710-07, 1951307, 17507463.
54. Witke W, Sharpe AH, Hartwig JH, Azuma T, Stossel TP, Kwiatkowski DJ. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 1995, 81:41-51. 10.1016/0092-8674(95)90369-0, 7720072.
55. Lin ECJ, Leak RK, Perez RG, Zigmond MJ. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. J Neurosci Res 2008, 86:108-117. 10.1002/jnr.21478, 17847117.
56. Liu B, Zhang H, Xu C, Yang G, Tao J, Huang J, Wu J, Duan X, Cao Y, Dong J. Neuroprotective effects of icariin on corticosterone-induced apoptosis in primary cultured rat hippocampal neurons. Brain Res 2010, 1375:59-67.
57. Wakade C, Khan MM, De Sevilla LM, Zhang QG, Mahesh VB, Brann DW. Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase. Endocrinology 2008, 149:367-379. 2194601, 17901229.
58. Zhang JZ, Jing L, Ma Y, Guo FY, Chang Y, Li PA. Monosialotetrahexosy-1 ganglioside attenuates diabetes-enhanced brain damage after transient forebrain ischemia and suppresses phosphorylation of ERK1/2 in the rat brain. Brain Res 2010, 1344:200-208. 2900456, 20546707.
59. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV. MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci USA 1999, 96:12866-12869. 10.1073/pnas.96.22.12866, 23136, 10536014.
60. Nguyen DN, Spapen H, Su F, Schiettecatte J, Shi L, Hachimi-Idrissi S, Huyghens L. Elevated serum levels of S-100 beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med 2006, 34:1967-1974. 10.1097/01.CCM.0000217218.51381.49, 16607230.
61. Patenaude J, D'Elia M, Hamelin C, Garrel D, Bernier J. Burn injury induces a change in T cell homeostasis affecting preferentially CD4+ T cells. J Leukoc Biol 2005, 77:141-150.
62. Smith DBJP, Herbert TJ, Lind SE. Quantitative measurement of plasma gelsolin and its incorporation into fibrin clots. J Lab Clin Med 1987, 110:189-195.